Market revenue in 2020 | USD 10.5 million |
Market revenue in 2028 | USD 22.0 million |
Growth rate | 9.7% (CAGR from 2020 to 2028) |
Largest segment | Oncology |
Fastest growing segment | Personalized Medicine |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Genetic Disorders, Oncology, Personalized Medicine, Other Applications |
Key market players worldwide | Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Illumina Inc, Sysmex Corp, Roche Holding AG, BioView, MetaSystems, Agilent Technologies Inc, Revvity Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular cytogenetics market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 39.05% in 2020. Horizon Databook has segmented the Saudi Arabia molecular cytogenetics market based on genetic disorders, oncology, personalized medicine, other applications covering the revenue growth of each sub-segment from 2018 to 2028.
In Saudi Arabia, the biotechnology industry has witnessed rapid growth since the past few years, which is anticipated to continue in the near future. Several biotechnology companies are inclined to the Saudi Arabian market and making continuous efforts through partnerships with local healthcare companies to enter the market.
For instance, in May 2021, Euformatics entered into a distribution partnership with Illumina’s distributor in Saudi Arabia AI Jeel Medical and Trading Co. This agreement covers Euformatics’ whole product portfolio to offer NGS test validation, quality control, and various interpretation software to laboratories and hospitals in the country.
Furthermore, high unmet clinical needs, rise in disposable incomes, and presence of well-established genomic research centers create an opportunity for growth in the molecular cytogenetics market. For example, the Human Cancer Genomic Research (HCGR) is developing a novel diagnostic and therapeutic strategy aimed at improving the management of cancer.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia molecular cytogenetics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia molecular cytogenetics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account